BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging &amp; Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The European School of Multimodality Imaging &amp; Therapy (ESMIT)
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging &amp; Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260924T090000
DTEND;TZID=Europe/Vienna:20260925T123000
DTSTAMP:20260819T123326
CREATED:20251004T070000Z
LAST-MODIFIED:20260710T101403Z
UID:2831-1790240400-1790339400@esmit.eanm.org
SUMMARY:Prostate Cancer Theranostics
DESCRIPTION:Radiolabelled prostate-specific membrane antigen (PSMA) is increasingly used for the diagnosis (i.e.\, staging and restaging) and treatment of patients with prostate cancer. Radionuclide PSMA therapy is a useful new treatment option in patients with metastatic castration-resistant prostate cancer (mCRPC) and potentially also in patients with hormone-sensitive prostate cancer. The course will cover the spectrum of radiolabelled PSMA tracers and techniques related to PSMA imaging\, from diagnosis to therapy\, with lectures\, interactive case discussions\, and relevant information for clinical practice. \n\n\n\n\n\n\n\nRegister nowRegistration is now open\, save yourself a seat! Register now\n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\nPSMA PET-CT imaging- science and practice  \n\n\n\n\nTo provide an overview of clinical applications\, normal biodistribution\, variants\, pitfalls and artefacts in PSMA PET-CT\n\n\n\nTo learn how to report PSMA PET-CT scans in a structured manner\n\n\n\n\n \n\n\n\nRadionuclide PSMA therapy-science and practice (177Lu-PSMA and 225Ac-PSMA therapies) \n\n\n\n\nTo gain knowledge on PSMA-based patients selection when planning radionuclide therapies\n\n\n\nTo become familiar with common clinical challenges and side effects management\, when implementing and delivering radionuclide therapies\n\n\n\nTo discuss current evidence and trends related to 177Lu-PSMA and 225Ac-PSMA therapies\n\n\n\nTo learn about new or emerging targets and radioisotopes for Prostate cancer management.\n\n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nGeneral nuclear medicine specialists\, residents\, radiologists and healthcare specialists who want to update their knowledge on molecular imaging of prostate cancer and radiolabelled PSMA therapy (theranostics). \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nProgrammeView the programme here\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDaniela Oprea-LagerSpeakerNijmegen\, The Netherlands \n\n\n\n\n\nKarolien GoffinSpeakerLeuven\, Belgium \n\n\n\n\n\nWolfgang FendlerSpeakerEssen\, Germany \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nNEW Department Package: If you send 5 participants from your department\, you will get an additional 6th seat for free for this course. Please get in touch with the ESMIT office if this is of interest to you. \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/prostate-cancer-theranostics-2/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20261112T090000
DTEND;TZID=Europe/Vienna:20261113T123000
DTSTAMP:20260819T123327
CREATED:20251004T070000Z
LAST-MODIFIED:20250930T145535Z
UID:2833-1794474000-1794573000@esmit.eanm.org
SUMMARY:Biomarker Assessment for an Early Biological Diagnosis of Alzheimer's Disease
DESCRIPTION:More information will come soon. \n\n\n\n\n\n\n\nRegister nowRegistration is now open\, save yourself a seat! Register now\n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\nMore info will come soon. \n\n\n\n \n\n\n\nTarget Audience\n\n\n\nMore info will come soon. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nProgrammeThe programme will come soon. View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeCancellation Policy\n\nCourse Fee               FREE \n\n\n\nCourse includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nCourse does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/biomarker-assessment-for-an-early-biological-diagnosis-of-alzheimers-disease/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20261203T090000
DTEND;TZID=Europe/Vienna:20261204T123000
DTSTAMP:20260819T123327
CREATED:20251004T070000Z
LAST-MODIFIED:20260818T093613Z
UID:2835-1796288400-1796387400@esmit.eanm.org
SUMMARY:Focus on Benign Thyroid Disease: From Thyroid Nodule to Hyperthyroidism and Immune Disease
DESCRIPTION:This two-day interactive course provides a comprehensive overview of the diagnosis and management of benign thyroid diseases. It covers the entire clinical pathway\, from thyroid physiology and the evaluation of thyroid nodules to hyperthyroidism\, autoimmune thyroid disorders\, and treatment-related thyroid dysfunction. Participants will gain practical knowledge on the use of neck ultrasound\, thyroid scintigraphy\, fine-needle aspiration biopsy\, cytology\, and the emerging role of PET imaging in selected clinical scenarios. The course also addresses evidence-based management strategies according to current international guidelines\, including radioactive iodine therapy for hyperthyroidism and the management of Graves’ disease\, thyroid-associated ophthalmopathy\, immune-mediated thyroid disorders\, and thyroid dysfunction induced by modern cancer therapies. The programme combines state-of-the-art lectures with interactive case discussions\, image interpretation sessions\, and quizzes\, providing participants with practical skills that can be directly implemented in daily clinical practice. \n\n\n\n\n\n\n\nRegister nowRegistration is now open\, save yourself a seat! Register now\n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\nUpon completion of this course\, participants will be able to: \n\n\n\n\nIntegrate multidisciplinary clinical and imaging findings into patient-centred decision-making through interactive case discussions.\n\n\n\n\n\nDescribe the physiology and pathophysiology of thyroid function and benign thyroid diseases. \n\n\n\n\n\nPerform a structured diagnostic work-up of patients with thyroid nodules and diffuse thyroid disease. \n\n\n\n\n\nInterpret thyroid ultrasound findings and apply current ultrasound risk stratification systems. \n\n\n\n\n\nUnderstand the indications\, techniques\, and interpretation of fine-needle aspiration biopsy and thyroid cytology classifications.\n\n\n\n\n\nSelect the appropriate nuclear medicine imaging modality\, including thyroid scintigraphy\, MIBI imaging\, and the potential role of PET in selected thyroid disorders. \n\n\n\n\n\nApply current international guidelines for the management of thyroid nodules. \n\n\n\n\n\nDevelop evidence-based treatment strategies for hyperthyroidism\, including patient selection for radioactive iodine therapy.\n\n\n\n\n\nRecognize and manage Graves’ disease\, thyroid-associated ophthalmopathy\, autoimmune thyroid diseases\, and treatment-related thyroid dysfunction. \n\n\n\n\n \n\n\n\nTarget Audience\n\n\n\nNuclear medicine specialists and physicians in training\, endocrinologists\, internal medicine specialists\, all physicians\, including surgeons\, with a particular interest in thyroid disorders.  \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nProgrammeThe programme will come soon. View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nMurat TuncelSpeakerAnkara\, Türkiye \n\n\n\n\n\nDaniel GrönerSpeaker \n\n\n\n\n\nDaria MaccoraSpeakerRome\, Italy \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nNEW Department Package: If you send 5 participants from your department\, you will get an additional 6th seat for free for this course. Please get in touch with the ESMIT office if this is of interest to you. \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/focus-on-benign-thyroid-disease-from-thyroid-nodule-to-hyperthyroidism-and-immune-disease-2/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course
END:VEVENT
END:VCALENDAR